Stolte, Thorald
Lopez-Ayala, Pedro
Reichl, Jakob
Pfenniger, Anna
Allegra, Giampiero
Leibundgut, Gregor
Kaiser, Christoph
Boeddinghaus, Jasper
Mahfoud, Felix
Mueller, Christian
Nestelberger, Thomas https://orcid.org/0000-0003-2173-5738
Funding for this research was provided by:
Swiss National Science Foundation (P400PM_191037/1)
Medizinische Abteilung der Margarete und Walter Lichtenstein-Stiftung (3MS1038)
Stiftung Professor Dr. Max Cloëtta
University of Basel
Article History
Received: 20 August 2024
Accepted: 29 November 2024
First Online: 11 December 2024
Declarations
:
: Thomas Nestelberger has received research support from the Swiss National Science Foundation (P400PM_191037/1), the Prof. Dr. Max Cloëtta Foundation, the Margarete und Walter Lichtenstein-Stiftung (3MS1038), and the University Hospital Basel as well as speaker honoraria/consulting honoraria from Edwards Lifesciences, Siemens, Beckman Coulter, Bayer, Ortho Clinical Diagnostics and Orion Pharma, outside the submitted work. Pedro Lopez-Ayala has received research grants from the Swiss Heart Foundation (FF20079 and FF21103) and speaker’s honoraria from Quidel, paid to the institution and outside the submitted work. Felix Mahfoud is supported by Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Forschungsgemeinschaft (SFB TRR219, Project-ID 322900939), and Deutsche Herzstiftung. Saarland University has received scientific support from Ablative Solutions, Medtronic and ReCor Medical. Until May 2024, FM has received speaker honoraria/consulting fees from Ablative Solutions, Amgen, Astra-Zeneca, Bayer, Boehringer Ingelheim, Inari, Medtronic, Merck, ReCor Medical, Servier, and Terumo. Christian Mueller has received research grants from the Swiss National Science Foundation, the Swiss Heart Foundation, the University Basel, the University Hospital Basel, Abbott, Astra Zeneca, Beckman Coulter, Boehringer Ingelheim, BRAHMS, Critical Diagnostics, Idorsia, Novartis, Ortho Clinical Diagnostics, Quidel, Roche, Siemens, Singulex, Sphingotec, and SpinChip, as well as speaker/consulting honoraria from Astra Zeneca, Bayer, Boehringer Ingelheim, BMS, Daiichi Sankyo, Idorsia, Osler, Novartis, Roche, Sanofi, Siemens, Singulex, and SpinChip, all paid to the institution. All other authors declare that they have no conflict of interest with this study and that they have critically reviewed the manuscript and approved the final version for submission. The manuscript and its contents have not been published previously and are not being considered for publications elsewhere in whole or in part in any language, including publicly accessible web sites or e-print servers.